161 related articles for article (PubMed ID: 34492311)
1. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis.
Hu Q; Liu M; You Y; Zhou G; Chen Y; Yuan H; Xie L; Han S; Zhu K
Free Radic Biol Med; 2021 Nov; 175():193-205. PubMed ID: 34492311
[TBL] [Abstract][Full Text] [Related]
2. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Qu C; Zheng D; Li S; Liu Y; Lidofsky A; Holmes JA; Chen J; He L; Wei L; Liao Y; Yuan H; Jin Q; Lin Z; Hu Q; Jiang Y; Tu M; Chen X; Li W; Lin W; Fuchs BC; Chung RT; Hong J
Hepatology; 2018 Sep; 68(3):1125-1139. PubMed ID: 29537660
[TBL] [Abstract][Full Text] [Related]
4. Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
Zhang Z; Zhao S; Yao Z; Wang L; Shao J; Chen A; Zhang F; Zheng S
Redox Biol; 2017 Apr; 11():322-334. PubMed ID: 28038427
[TBL] [Abstract][Full Text] [Related]
5. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
6. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
Zhao Y; Wang Z; Feng D; Zhao H; Lin M; Hu Y; Zhang N; Lv L; Gao Z; Zhai X; Tian X; Yao J
Theranostics; 2019; 9(5):1510-1522. PubMed ID: 30867846
[No Abstract] [Full Text] [Related]
7. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl α-ketoglutarate reduces CCl
Zhao J; Peng L; Cui R; Guo X; Yan M
Biochem Biophys Res Commun; 2016 Dec; 481(1-2):90-96. PubMed ID: 27823933
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation.
Yu Y; Sun X; Gu J; Yu C; Wen Y; Gao Y; Xia Q; Kong X
Int J Biol Sci; 2016; 12(10):1225-1235. PubMed ID: 27766037
[TBL] [Abstract][Full Text] [Related]
10. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
[TBL] [Abstract][Full Text] [Related]
11. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl
Chang CC; Yang Y; Gao DY; Cheng HT; Hoang B; Chao PH; Chen LH; Bteich J; Chiang T; Liu JY; Li SD; Chen Y
J Drug Target; 2018; 26(5-6):516-524. PubMed ID: 29251522
[TBL] [Abstract][Full Text] [Related]
13. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
[TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2.
Song Z; Liu X; Zhang W; Luo Y; Xiao H; Liu Y; Dai G; Hong J; Li A
J Transl Med; 2022 Apr; 20(1):157. PubMed ID: 35382859
[TBL] [Abstract][Full Text] [Related]
15. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Sung YC; Liu YC; Chao PH; Chang CC; Jin PR; Lin TT; Lin JA; Cheng HT; Wang J; Lai CP; Chen LH; Wu AY; Ho TL; Chiang T; Gao DY; Duda DG; Chen Y
Theranostics; 2018; 8(4):894-905. PubMed ID: 29463989
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway.
Gan D; Zhang W; Huang C; Chen J; He W; Wang A; Li B; Zhu X
J Cell Physiol; 2018 Oct; 233(10):6799-6813. PubMed ID: 29672850
[TBL] [Abstract][Full Text] [Related]
17. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis.
Zhang Z; Guo M; Zhao S; Shao J; Zheng S
Free Radic Biol Med; 2016 Dec; 101():272-283. PubMed ID: 27989749
[TBL] [Abstract][Full Text] [Related]
18. Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15.
Dong G; Ma M; Lin X; Liu H; Gao D; Cui J; Ren Z; Chen R
Exp Cell Res; 2018 Sep; 370(2):468-477. PubMed ID: 30146065
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.
Zhang D; Zhang L; Chen G; Xu Y; Yang H; Xiao Z; Chen J; Mu Y; Zhang H; Liu W; Liu P
Pharm Biol; 2020 Dec; 58(1):1229-1243. PubMed ID: 33332219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
